Keyphrases
Schizophrenia
50%
Schizophrenic Patients
46%
Clozapine
42%
Functional Connectivity
33%
Antipsychotics
31%
Chronic Schizophrenia
28%
Motor Vehicle Accident
28%
Posttraumatic Stress Disorder
24%
Clozapine Treatment
16%
Affective Context
14%
Risperidone
14%
Network Dynamics
14%
Electroconvulsive Therapy
14%
Risky Decisions
14%
Global Functional Connectivity
14%
Medial Prefrontal Cortex (mPFC)
14%
Inhibition Capacity
14%
General Health
14%
Olanzapine
14%
Capacity Decision
14%
Behavioral State
14%
Cohesion Index
14%
Accident Victims
14%
Clinical Characteristics
14%
Long-term Antipsychotic Treatment
14%
Substance Abuse
14%
Outpatient Clinic
14%
Network Cohesion
14%
Demographic Characteristics
14%
Posttraumatic Stress Symptoms
14%
Overreporting
14%
Primary Care Setting
14%
Israel
14%
Early-onset Schizophrenia
14%
Randomized Trial
14%
Europe
14%
Long-acting Injectable Antipsychotics
14%
Embodied Simulation
11%
Long-acting Injectable
11%
All-cause Discontinuation
11%
Body Mass Index
10%
Inferior Frontal Gyrus
9%
Inhibition Control
9%
Corpus Callosum
9%
Theory of Mind
9%
Healthy Controls
9%
Combined Treatment
8%
Risky Decision Making
7%
Treatment Group
7%
Minnesota Multiphasic Personality Inventory-2 (MMPI-2)
6%
Neuroscience
Dementia Praecox
100%
Clozapine
42%
Typical Antipsychotic
31%
Antipsychotic
28%
Functional Connectivity
28%
Risperidone
14%
Prefrontal Cortex
14%
Substance Abuse
14%
Electroconvulsive Therapy
14%
Olanzapine
14%
Posttraumatic Stress Disorder
14%
Theory of Mind
10%
Corpus Callosum
7%
Body Mass Index
7%
Inferior Frontal Gyrus
7%
Decision-Making
7%
Paliperidone
7%
Pharmacology, Toxicology and Pharmaceutical Science
Clozapine
42%
Antipsychotic
31%
Typical Antipsychotic
31%
Schizophrenia
28%
Risperidone
14%
Posttraumatic Stress Disorder
14%
Olanzapine
14%
Observational Study
14%
Paliperidone
7%
Disease
6%
Remission
5%